% Encoding: UTF-8
﻿
@Article{Masyita2024,
  author                     = {Masyita, Ayu and Firdayani, Firdayani and Listiana, Shelvi and Besari, Ariza Yandwiputra},
  journal                    = {BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS},
  title                      = {Emodin derivatives as novel potent DPP-4 inhibitors: Design, synthesis, and in vitro evaluation},
  year                       = {2024},
  issn                       = {0006-291X},
  month                      = nov,
  volume                     = {735},
  abstract                   = {Dipeptidyl peptidase-4 (DPP-4) inhibitors have gained recognition as
   effective agents for lowering blood sugar levels, significantly
   improving glycemic control for individuals with type 2 diabetes mellitus
   (T2DM). Emodin, an anthraquinone derived from the traditional herbs
   rhubarb (Rheum officinale) and Polygonum cuspidatum, has been identified
   as an important component in the development of new treatments for
   diabetes. In the present work, we explored the DPP-4 inhibitory activity
   of emodin derivatives. This study focused on the design, synthesis, and
   evaluation of emodin derivatives for their in vitro DPP-4 inhibitory
   activity. Molecular docking studies indicated that 3-o-toluoyl emodin
   (OTEM) had the lowest docking score (-134.073) against the DPP-4 protein
   among the tested compounds. OTEM also achieved the highest drug-likeness
   score of 0.56 and demonstrated DPP-4 inhibitory activity, with an IC50
   value of 0.77 mu M. Furthermore, structure-activity relationship (SAR)
   analysis suggested that the addition of an ortho-toluoyl group at the
   C-3 position could enhance DPP-4 inhibition. Additionally, quantitative
   structure-activity relationship (QSAR) model assessments revealed that
   log P was the only descriptor significantly influencing DPP-4 inhibitory
   activity. Therefore, the current study indicates that OTEM could serve
   as a promising lead compound to address the demand for antidiabetic
   agents.},
  address                    = {525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA},
  affiliation                = {Masyita, A; Firdayani, F (Corresponding Author), Natl Res \& Innovat Agcy BRIN, Res Org Hlth, Res Ctr Vaccine \& Drugs, Cibinong Bogor, Indonesia. Masyita, Ayu; Firdayani, Firdayani; Listiana, Shelvi; Besari, Ariza Yandwiputra, Natl Res \& Innovat Agcy BRIN, Res Org Hlth, Res Ctr Vaccine \& Drugs, Cibinong Bogor, Indonesia.},
  affiliations               = {National Research \& Innovation Agency of Indonesia (BRIN)},
  article-number             = {150867},
  author-email               = {ayum002@brin.go.id firdayani@brin.go.id},
  cited-references           = {Berger T.A., 2024, Comprehensive Chirality, P355, DOI {[}10.1016/B978-0-32-390644-9.00013-5, DOI 10.1016/B978-0-32-390644-9.00013-5]. Chatterjee S, 2017, LANCET, V389, P2239, DOI 10.1016/S0140-6736(17)30058-2. Clark DE, 2000, DRUG DISCOV TODAY, V5, P49, DOI 10.1016/S1359-6446(99)01451-8. Vo DV, 2021, BIOORGAN MED CHEM, V29, DOI 10.1016/j.bmc.2020.115861. Firdayani, 2022, IOP Conference Series: Earth and Environmental Science, V976, DOI 10.1088/1755-1315/976/1/012054. Firdayani F., 2023, Jurnal Kimia Valensi, V9, P306, DOI {[}10.15408/jkv.v9i2.34654, DOI 10.15408/JKV.V9I2.34654]. He ZX, 2015, CLIN EXP PHARMACOL P, V42, P125, DOI 10.1111/1440-1681.12332. Hosey CM, 2017, COMPREHENSIVE MEDICINAL CHEMISTRY III, VOL 4: EXPERIMENTAL ADME AND TOXICOLOGY, P102, DOI 10.1016/B978-0-12-409547-2.12375-3. Ivanov SM, 2018, J CHEM INF MODEL, V58, P8, DOI 10.1021/acs.jcim.7b00568. Kaur P, 2018, CURR DRUG TARGETS, V19, P1738, DOI 10.2174/1389450119666180727142902. Khan Z, 2021, J IND ENG CHEM, V103, P80, DOI 10.1016/j.jiec.2021.07.018. Li N, 2018, EUR J MED CHEM, V151, P145, DOI 10.1016/j.ejmech.2018.03.041. Ma HH, 2023, FITOTERAPIA, V168, DOI 10.1016/j.fitote.2023.105549. Maslov IO, 2022, PHARMACEUTICALS-BASE, V15, DOI 10.3390/ph15030273. Mourad AAE, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14020144. Paudel P, 2020, ACS OMEGA, V5, P26720, DOI 10.1021/acsomega.0c03649. Shaikh S, 2022, FRONT MOL BIOSCI, V9, DOI 10.3389/fmolb.2022.1024764. Wang ZK, 2017, PEERJ, V5, DOI 10.7717/peerj.3283. Yousefnejad F, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-39424-8. Zhu L, 2017, DEVELOPING SOLID ORAL DOSAGE FORMS: PHARMACEUTICAL THEORY AND PRACTICE, 2ND EDITION, P297, DOI 10.1016/B978-0-12-802447-8.00011-X.},
  da                         = {2024-11-29},
  doc-delivery-number        = {K4U3P},
  doi                        = {10.1016/j.bbrc.2024.150867},
  earlyaccessdate            = {OCT 2024},
  eissn                      = {1090-2104},
  funding-acknowledgement    = {National Research and Innovation Agency (BRIN); Indonesia Endowment Fund for Education (LPDP); Scheme Research and Innovation for Advanced Indonesia (RIIM) {[}82/II.7/HK/2022]},
  funding-text               = {This work was supported by grants from National Research and Innovation Agency (BRIN) and Indonesia Endowment Fund for Education (LPDP) with the scheme Research and Innovation for Advanced Indonesia (RIIM) (No. 82/II.7/HK/2022) .},
  groups                     = {Emodin, Metabolitos},
  journal-iso                = {Biochem. Biophys. Res. Commun.},
  keywords                   = {Antidiabetic; DPP-4 inhibitor; Emodin; T2DM},
  keywords-plus              = {PREDICTION},
  language                   = {English},
  number-of-cited-references = {20},
  publisher                  = {ACADEMIC PRESS INC ELSEVIER SCIENCE},
  research-areas             = {Biochemistry \& Molecular Biology; Biophysics},
  researcherid-numbers       = {Masyita, Ayu/HPE-3256-2023},
  times-cited                = {0},
  type                       = {Article},
  unique-id                  = {WOS:001343837900001},
  usage-count-last-180-days  = {4},
  usage-count-since-2013     = {4},
  web-of-science-categories  = {Biochemistry \& Molecular Biology; Biophysics},
  web-of-science-index       = {Science Citation Index Expanded (SCI-EXPANDED)},
}

@Article{Rachin2024,
  author    = {Rachin, A.P. and Sharov, M.N. and Karpov, S.M. and Rachin, S.A. and Prokofieva, Y.S. and Parsamyan, R.R.},
  journal   = {Comorbidity neurology},
  title     = {Diabetic Polyneuropathy: from Pathogenesis to Therapy and Prevention (to Help the General Practitioner)},
  year      = {2024},
  issn      = {3034-185X},
  month     = sep,
  number    = {3},
  pages     = {101--108},
  volume    = {1},
  doi       = {10.62505/3034-185x-2024-1-3-101-108},
  groups    = {Fundamento teórico},
  publisher = {MEDIKON LLC},
}

@Book{Publications2024,
  author    = {Exon Publications},
  editor    = {Brisbane (AU)},
  publisher = {Exon Publication},
  title     = {Diabetes tipo 2: Educación Pública},
  year      = {2024},
  month     = oct,
  doi       = {https://doi.org/10.36255/type-2-diabetes-public-education},
  groups    = {Fundamento teórico},
}

@Article{Javaid2022,
  author  = {Sobia Javaid, Maleeha Zafar},
  title   = {Comparative Metabolic Properties of Aloe Vera Extracts and Sitagliptin in Diabetic Rats},
  journal = {Journal of Rawalpindi Medical College (JRMC)},
  year    = {2022},
  doi     = {https://doi.org/10.37939/jrmc.v26i3.1746},
}

@Article{Lu2023,
  author    = {Lu, Gen and Pan, Fei and Li, Xiaotong and Zhu, Zehui and Zhao, Lei and Wu, Ya and Tian, Wenli and Peng, Wenjun and Liu, Jinling},
  journal   = {Journal of Biomolecular Structure and Dynamics},
  title     = {Virtual screening strategy for anti-DPP-IV natural flavonoid derivatives based on machine learning},
  year      = {2023},
  issn      = {1538-0254},
  month     = jul,
  number    = {13},
  pages     = {6645--6659},
  volume    = {42},
  doi       = {10.1080/07391102.2023.2237594},
  publisher = {Informa UK Limited},
}

@Article{Maya2024,
  author    = {Maya and Yadav, Raj KS},
  journal   = {International Journal of Pharmaceutical Sciences and Drug Research},
  title     = {Molecular Docking and ADMET Profiling of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin from Dalbergia sissoo: In Silico Prediction in Antidiabetic Potential},
  year      = {2024},
  issn      = {0975-248X},
  month     = sep,
  pages     = {841--854},
  doi       = {10.25004/ijpsdr.2024.160512},
  publisher = {International Journal of Pharmaceutical Sciences and Drug Research},
}

@Article{Zollapi2023,
  author    = {Zollapi, Nuraliana Najwa Hamsah and Taib, Raihan and Zakaria, Nurfatini and Khayat, Mohd Ezuan},
  journal   = {Journal of Biochemistry, Microbiology and Biotechnology},
  title     = {Identification of Dipeptidyl-Peptidase 4 (DPP-4) Inhibitors from Miracle Berry Fruit (Synsepalum dulcificum) Extract},
  year      = {2023},
  issn      = {2289-5779},
  month     = jul,
  number    = {1},
  pages     = {42--47},
  volume    = {11},
  doi       = {10.54987/jobimb.v11i1.805},
  publisher = {Hibiscus Publisher Enterprise},
}

@Article{Suleiman2024,
  author    = {Suleiman, Marharyta M. and Semenets, Anton P. and Kobzar, Nataliia P. and Perekhoda, Lina O.},
  journal   = {урнал органічної та фармацевтичної хімії},
  title     = {The Theoretical Substantiation of the Targeted Search for New DPP4 Inhibitors. Computational Studies of Potential Candidates},
  year      = {2024},
  issn      = {2308-8303},
  month     = jun,
  number    = {1},
  pages     = {3--12},
  volume    = {22},
  doi       = {10.24959/ophcj.24.302677},
  publisher = {National University of Pharmacy},
}

@Article{Ushasree2024,
  author    = {Ushasree, Mrudulakumari Vasudevan and Jia, Qi and Do, Seon Gil and Lee, Eun Yeol},
  journal   = {Biotechnology Advances},
  title     = {New opportunities and perspectives on biosynthesis and bioactivities of secondary metabolites from Aloe vera},
  year      = {2024},
  issn      = {0734-9750},
  month     = may,
  pages     = {108325},
  volume    = {72},
  doi       = {10.1016/j.biotechadv.2024.108325},
  publisher = {Elsevier BV},
}

@Article{Prasannaraja2020,
  author    = {Prasannaraja, C. and Kamalanathan, A. S. and Vijayalakshmi, M. A. and Venkataraman, Krishnan},
  journal   = {Preparative Biochemistry; Biotechnology},
  title     = {A dipyrrole derivative from Aloe vera inhibits an anti-diabetic drug target Dipeptidyl Peptidase (DPP)-IV in vitro},
  year      = {2020},
  issn      = {1532-2297},
  month     = jan,
  number    = {5},
  pages     = {511--520},
  volume    = {50},
  doi       = {10.1080/10826068.2019.1710712},
  groups    = {Dipyrrole, Metabolitos},
  publisher = {Informa UK Limited},
}

@Article{GuevaraTirado2024,
  author    = {Guevara Tirado, Alberto},
  journal   = {Revista de la Sociedad Argentina de Diabetes},
  title     = {Determinación del riesgo de diabetes mellitus tipo 2 en la población peruana. Encuesta Demográfica y de Salud Familiar 2022},
  year      = {2024},
  issn      = {0325-5247},
  month     = apr,
  number    = {1},
  pages     = {34--40},
  volume    = {58},
  doi       = {10.47196/diab.v58i1.727},
  publisher = {Editorial Biotecnologica S.R.L.},
}

@Article{DeLaTorre2024,
  author    = {De La Torre, Sandra and Cuesta, Sebastián A. and Calle, Luis and Mora, José R. and Paz, Jose L. and Espinoza-Montero, Patricio J. and Flores-Sumoza, Máryury and Márquez, Edgar A.},
  journal   = {Computational Biology and Chemistry},
  title     = {Computational approaches for lead compound discovery in dipeptidyl peptidase-4 inhibition using machine learning and molecular dynamics techniques},
  year      = {2024},
  issn      = {1476-9271},
  month     = oct,
  pages     = {108145},
  volume    = {112},
  doi       = {10.1016/j.compbiolchem.2024.108145},
  publisher = {Elsevier BV},
}

@Article{Singhal2024,
  author    = {Singhal, Shipra and Manikrao Patil, Vaishali and Verma, Saroj and Masand, Neeraj},
  journal   = {Bioorganic Chemistry},
  title     = {Recent advances and structure-activity relationship studies of DPP-4 inhibitors as anti-diabetic agents},
  year      = {2024},
  issn      = {0045-2068},
  month     = may,
  pages     = {107277},
  volume    = {146},
  doi       = {10.1016/j.bioorg.2024.107277},
  publisher = {Elsevier BV},
}

@Article{Shao2024,
  author    = {Shao, Dong-Wei and Zhao, Li-Jie and Sun, Jin-Feng},
  journal   = {European Journal of Medicinal Chemistry},
  title     = {Synthesis and clinical application of representative small-molecule dipeptidyl Peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus (T2DM)},
  year      = {2024},
  issn      = {0223-5234},
  month     = jun,
  pages     = {116464},
  volume    = {272},
  doi       = {10.1016/j.ejmech.2024.116464},
  publisher = {Elsevier BV},
}

@Article{Kathiraven2024,
  author    = {Kathiraven, A. and Srimathi, R. and M.K, Kathiravan.},
  journal   = {Research Journal of Pharmacy and Technology},
  title     = {Exploring the Relationship of DPP-IV Inhibitors in the treatment of Diabetes and Cardiovascular Disease},
  year      = {2024},
  issn      = {0974-3618},
  month     = aug,
  pages     = {3553--3559},
  doi       = {10.52711/0974-360x.2024.00555},
  publisher = {A and V Publications},
}

@Article{Kazeem2021,
  author    = {Kazeem, Mutiu and Bankole, Habeeb and Ogunrinola, Olabisi and Wusu, Adedoja and Kappo, Abidemi},
  journal   = {Food Frontiers},
  title     = {Functional foods with dipeptidyl peptidase‐4 inhibitory potential and management of type 2 diabetes: A review},
  year      = {2021},
  issn      = {2643-8429},
  month     = feb,
  number    = {2},
  pages     = {153--162},
  volume    = {2},
  doi       = {10.1002/fft2.71},
  publisher = {Wiley},
}

﻿
@Article{Budiastutik2022,
  author                     = {Budiastutik, Indah and Subagio, Hertanto Wahyu and Kartasurya, Martha Irene and Widjanarko, Bagoes and Kartini, Apoina and Soegiyanto and Suhartono, Suhartono},
  journal                    = {JOURNAL OF PHARMACY \& PHARMACOGNOSY RESEARCH},
  title                      = {The effect of <i>Aloe vera</i> on fasting blood glucose levels in pre-diabetes and type 2 diabetes mellitus: A systematic review and meta-analysis},
  year                       = {2022},
  issn                       = {0719-4250},
  month                      = jul,
  number                     = {4},
  pages                      = {737-747},
  volume                     = {10},
  abstract                   = {Context: : Aloe vera is a traditional medicinal plant that shows a wide
   range of biological activities. Previous studies demonstrated the
   antihyperglycemic effect of Aloe vera but with inconsistent results.
   Aims: To quantitatively summarize the effect of Aloe vera on fasting
   blood glucose in pre-diabetes and type 2 diabetes mellitus by a
   meta-analysis.
   Methods: PubMed, Scopus, Springer Link, Science Direct, Proquest, and
   Google Scholar were used to identify clinical trials evaluating the
   effect of Aloe vera on fasting blood glucose published between 2011 and
   2021. The inclusion criteria were: (1) original research with a clinical
   trial design evaluating the effect of Aloe vera on fasting blood glucose
   in pre-diabetes and/or type 2 diabetes mellitus; (2) providing the data
   of the mean fasting blood glucose and standard deviation in both control
   and intervention group, and; (3) Aloe vera was used as the only
   intervention. The pooled effect of Aloe vera on fasting blood glucose
   was evaluated using the random effect model, and publication bias was
   assessed by Funnel plots and Fail Safe-N.
   Results: A total of 25 trials were included from 13 publications
   involving 642 patients. The results showed that Aloe vera significantly
   reduced fasting blood glucose (-0.35 {[}95\% CI, -1454, -0.616] mg/dL;
   p<0.001) compared to control. Aloe vera might have a more remarkable
   effect in males, BMI not more than 30 mg/kg(2), type 2 diabetes
   mellitus, administered for >= 8 weeks, dose at 200 mg, and capsule
   administration. However, a high heterogeneity across the studies was
   found.
   Conclusions: Aloe vera may reduce fasting blood glucose in pre-diabetes
   and type 2 diabetes mellitus. However, further study with a well-design
   and standardized preparation is needed to emphasize the effect of Aloe
   vera on blood glucose control.},
  address                    = {ANGAMOS 0610, ANTOFAGASTA, 00000, CHILE},
  affiliation                = {Subagio, HW (Corresponding Author), Diponegoro Univ, Fac Med, Semarang, Indonesia. Budiastutik, Indah; Widjanarko, Bagoes, Diponegoro Univ, Fac Publ Hlth, Doctoral Program Publ Hlth, Semarang, Indonesia. Subagio, Hertanto Wahyu, Diponegoro Univ, Fac Med, Semarang, Indonesia. Kartasurya, Martha Irene; Kartini, Apoina, Diponegoro Univ, Fac Publ Hlth, Publ Hlth Nutr Dept, Semarang, Indonesia. Soegiyanto, Univ Negeri Semarang, Doctoral Program Sport Educ, Semarang, Indonesia. Suhartono, Suhartono, Diponegoro Univ, Fac Publ Hlth, Dept Environm Hlth, Semarang, Indonesia.},
  affiliations               = {Diponegoro University; Diponegoro University; Diponegoro University; Universitas Negeri Semarang; Diponegoro University},
  author-email               = {hertantows@lecturer.undip.ac.id},
  cited-references           = {Afaf I. A., 2008, Journal of Applied Sciences Research, P1841. Akpan U. P., 2014, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V5, P647. Alinejad-Mofrad S, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0137-2. American Diabetes Association, 2019, Clin Diabetes, V37, P11, DOI 10.2337/cd18-0105. American Diabetes Association, 2014, DIABETES CARE, V37, pS81, DOI {[}DOI 10.2337/dc14-S081, 10.2337/dc14-S081]. Anand S, 2010, FEBS LETT, V584, P3170, DOI 10.1016/j.febslet.2010.06.004. Ariska A., 2019, J TELENUR, V1, P157. Arora D, 2009, J FOOD SCI TECH MYS, V46, P160. Bansal N, 2015, WORLD J DIABETES, V6, P296, DOI 10.4239/wjd.v6.i2.296. Beppu H, 2006, J ETHNOPHARMACOL, V103, P468, DOI 10.1016/j.jep.2005.10.034. But A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113162. Chen H, 2012, BIOMETRICS, V68, P1278, DOI 10.1111/j.1541-0420.2012.01761.x. Choi HC, 2013, NUTRITION, V29, P1110, DOI 10.1016/j.nut.2013.02.015. Choudhary M, 2014, J FOOD SCI TECH MYS, V51, P90, DOI 10.1007/s13197-011-0459-0. Dall TM, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0155. Devaraj S, 2013, METAB SYNDR RELAT D, V11, P35, DOI 10.1089/met.2012.0066. Ezuruike UF, 2014, J ETHNOPHARMACOL, V155, P857, DOI 10.1016/j.jep.2014.05.055. Fareed M, 2017, INT J MED RES HEALTH, V6, P125. Febria SS, 2019, J KESEHAT MED SAINTI, V10, P77. Foadoddini M., 2020, MOD CARE J, V17, DOI 10.5812/modernc.100927. Hostalek Ulrike, 2019, Clin Diabetes Endocrinol, V5, P5, DOI 10.1186/s40842-019-0080-0. Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193. Huseini H. F., 2012, Journal of Medicinal Plants, V11, P19. Huseini HF, 2012, PLANTA MED, V78, P311, DOI 10.1055/s-0031-1280474. Joseph J., 2018, INT J HEAL SCI RES, V8, P135. Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482. Krass I, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017725. Kumar R, 2019, PHYTOMEDICINE, V60, DOI 10.1016/j.phymed.2019.152996. Malinti E., 2019, J SK KEPERAWATAN, V5, P39. Manjunath K., 2016, National Journal of Physiology, Pharmacy and Pharmacology, V6, P471. Misawa E, 2012, J AGR FOOD CHEM, V60, P2799, DOI 10.1021/jf204465j. Moher D, 2009, BMJ-BRIT MED J, V339, DOI {[}10.1186/2046-4053-4-1, 10.1136/bmj.b2535, 10.1136/bmj.i4086, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.07.299, 10.1016/j.ijsu.2010.02.007, 10.1371/journal.pmed.1000097]. Nair B, 2019, INDIAN DERMATOL ONL, V10, P193, DOI 10.4103/idoj.IDOJ\_475\_18. Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024. Okyar A, 2001, PHYTOTHER RES, V15, P157, DOI 10.1002/ptr.719. Pandey A, 2011, J PHARM BIOALLIED SC, V3, P504, DOI 10.4103/0975-7406.90103. Poolsup N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215840. Rajasekaran S, 2006, CLIN EXP PHARMACOL P, V33, P232, DOI 10.1111/j.1440-1681.2006.04351.x. Rajasekaran S, 2005, PHARMACOL REP, V57, P90. Ryan JT, 2011, NUTRIENTS, V3, P765, DOI 10.3390/nu3090765. Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843. Sahu P. K., 2013, Pharmacology and Pharmacy, V4, P599, DOI 10.4236/pp.2013.48086. Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1435. Shin Eunju, 2011, Immune Netw, V11, P107, DOI 10.4110/in.2011.11.2.107. Slopien R, 2018, MATURITAS, V117, P6, DOI 10.1016/j.maturitas.2018.08.009. Suksomboon N, 2016, J CLIN PHARM THER, V41, P180, DOI 10.1111/jcpt.12382. Surjushe Amar, 2008, Indian J Dermatol, V53, P163, DOI 10.4103/0019-5154.44785. Surya N, 2020, INDIAN J PUBLIC HEAL, V11, P324. Tabák AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9. Wang HP, 2015, J CLIN HYPERTENS, V17, P223, DOI 10.1111/jch.12473. Wojdylo A, 2021, FOOD CHEM, V339, DOI 10.1016/j.foodchem.2020.127888. Zarrintan A., 2015, Pharmaceutical Sciences, V21, P65. Zhang HY, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00658. Zhang YY, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070388.},
  da                         = {2024-12-14},
  doc-delivery-number        = {3C4HD},
  journal-iso                = {J. Pharm. Pharmacogn. Res.},
  keywords                   = {Aloe vera; hyperglycemia; meta-analysis; systematic reviews},
  keywords-plus              = {GEL EXTRACT; LEAF GEL; SUPPLEMENTATION; PREVALENCE; EFFICACY; OBESITY},
  language                   = {English},
  number-of-cited-references = {54},
  publisher                  = {JOURNAL PHARMACY \& PHARMACOGNOSY RESEARCH-JPPRES},
  research-areas             = {Pharmacology \& Pharmacy},
  researcherid-numbers       = {Suhartono, Suhartono/GQP-8338-2022 Kartini, Apoina/GQH-6206-2022 Widjanarko, Bagoes/ABI-1901-2020 Subagio, Hertanto Wahyu/GQH-6099-2022 Kartasurya, Martha Irene/GPP-2780-2022},
  times-cited                = {2},
  type                       = {Review},
  unique-id                  = {WOS:000828584800010},
  usage-count-last-180-days  = {0},
  usage-count-since-2013     = {6},
  web-of-science-categories  = {Pharmacology \& Pharmacy},
  web-of-science-index       = {Emerging Sources Citation Index (ESCI)},
}

@Comment{jabref-meta: databaseType:bibtex;}
